Biochemical and in silico identification of the active site and the catalytic mechanism of the circadian deadenylase HESPERIN
| dc.creator | Beta R.A.A., Kyritsis A., Douka V., Papanastasi E., Rizouli M., Leonidas D.D., Vlachakis D., Balatsos N.A.A. | en |
| dc.date.accessioned | 2023-01-31T07:38:10Z | |
| dc.date.available | 2023-01-31T07:38:10Z | |
| dc.date.issued | 2022 | |
| dc.identifier | 10.1002/2211-5463.13011 | |
| dc.identifier.issn | 22115463 | |
| dc.identifier.uri | http://hdl.handle.net/11615/71624 | |
| dc.description.abstract | The 24-h molecular clock is based on the stability of rhythmically expressed transcripts. The shortening of the poly(A) tail of mRNAs is often the first and rate-limiting step that determines the lifespan of a mRNA and is catalyzed by deadenylases. Herein, we determine the catalytic site of Hesperin, a recently described circadian deadenylase in plants, using a modified site-directed mutagenesis protocol and a custom vector, pATHRA. To explore the catalytic efficiency of AtHESPERIN, we investigated the effect of AMP and neomycin, and used molecular modeling simulations to propose a catalytic mechanism. Collectively, the biochemical and in silico results classify AtHESPERIN in the exonuclease–endonuclease–phosphatase deadenylase superfamily and contribute to the understanding of the intricate mechanisms of circadian mRNA turnover. © 2020 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. | en |
| dc.language.iso | en | en |
| dc.source | FEBS Open Bio | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85129235912&doi=10.1002%2f2211-5463.13011&partnerID=40&md5=4360a12c2fd9fa2fd506fc500f7cb0d9 | |
| dc.subject | alanine | en |
| dc.subject | enzyme | en |
| dc.subject | framycetin | en |
| dc.subject | hesperin | en |
| dc.subject | messenger RNA | en |
| dc.subject | oligomer | en |
| dc.subject | polyacrylamide gel | en |
| dc.subject | recombinant protein | en |
| dc.subject | thrombin | en |
| dc.subject | unclassified drug | en |
| dc.subject | affinity labeling | en |
| dc.subject | alpha helix | en |
| dc.subject | Article | en |
| dc.subject | bacterial cell | en |
| dc.subject | biocatalysis | en |
| dc.subject | biochemical analysis | en |
| dc.subject | catalytic efficiency | en |
| dc.subject | computer model | en |
| dc.subject | conformational transition | en |
| dc.subject | controlled study | en |
| dc.subject | enzyme active site | en |
| dc.subject | enzyme activity | en |
| dc.subject | enzyme conformation | en |
| dc.subject | enzyme kinetics | en |
| dc.subject | enzyme purification | en |
| dc.subject | enzyme structure | en |
| dc.subject | hydrogen bond | en |
| dc.subject | molecular cloning | en |
| dc.subject | molecular interaction | en |
| dc.subject | molecular model | en |
| dc.subject | molecular weight | en |
| dc.subject | native polyacrylamide gel electrophoresis | en |
| dc.subject | nonhuman | en |
| dc.subject | nucleotide sequence | en |
| dc.subject | oligomerization | en |
| dc.subject | polyacrylamide gel electrophoresis | en |
| dc.subject | RNA sequence | en |
| dc.subject | site directed mutagenesis | en |
| dc.subject | catalysis | en |
| dc.subject | genetics | en |
| dc.subject | Catalysis | en |
| dc.subject | Catalytic Domain | en |
| dc.subject | RNA, Messenger | en |
| dc.subject | John Wiley and Sons Inc | en |
| dc.title | Biochemical and in silico identification of the active site and the catalytic mechanism of the circadian deadenylase HESPERIN | en |
| dc.type | journalArticle | en |
Αρχεία σε αυτό το τεκμήριο
| Αρχεία | Μέγεθος | Τύπος | Προβολή |
|---|---|---|---|
|
Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο. |
|||

